Optimel Manuka Forte Eye Gel
NDC Package 73024-429-10
Package Information
Optimel Manuka Forte Eye Gel (glycerin) gel is a medication used to relieve occasional constipation. This formulation utilizes a gel delivery system. Marketed by Melcare Biomedical Pty Ltd, this product is identified by NDC 73024-429 and is authorized under FDA application M014.
Identification & Billing
- RxCUI: 2179641 - glycerin 0.2 % Opthalmic Gel
- RxCUI: 2179641 - glycerin 0.002 MG/MG Ophthalmic Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 73024 - Melcare Biomedical Pty Ltd
- 73024-429 - Optimel Manuka Forte Eye Gel
- 73024-429-10 - 1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER
- 73024-429 - Optimel Manuka Forte Eye Gel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 73024-429-10 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 10 ml in 1 bottle, dropper of Optimel Manuka Forte Eye Gel, a human over the counter drug labeled by Melcare Biomedical Pty Ltd. This gel is formulated for ophthalmic use and contains glycerin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Melcare Biomedical Pty Ltd on July 19, 2019. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This product is used to relieve occasional constipation. Glycerin belongs to a class of drugs known as hyperosmotic laxatives. It works by drawing water into the intestines. This effect usually results in a bowel movement within 15 to 60 minutes. For adults, the normal frequency of bowel movements varies from once daily to 1 to 2 times weekly. For preschool-aged children, the normal frequency of bowel movements varies from once daily to once every other day. Constipation is best treated by drinking plenty of fluids, eating foods high in fiber, and exercising regularly.
How is this Melcare Biomedical Pty Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 73024042910. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.